Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Relationship Between PNPLA3 rs738409 Polymorphism and Decreased Kidney Function in Children With NAFLD
Giovanni Targher, Alessandro Mantovani, Anna Alisi, et al.
Hepatology (2019) Vol. 70, Iss. 1, pp. 142-153
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Complications, morbidity and mortality of nonalcoholic fatty liver disease
Alessandro Mantovani, Eleonora Scorletti, Antonella Mosca, et al.
Metabolism (2020) Vol. 111, pp. 154170-154170
Open Access | Times Cited: 448
NAFLD as a driver of chronic kidney disease
Christopher D. Byrne, Giovanni Targher
Journal of Hepatology (2020) Vol. 72, Iss. 4, pp. 785-801
Open Access | Times Cited: 349
Association of metabolic dysfunction-associated fatty liver disease with kidney disease
Ting-Yao Wang, Rui-Fang Wang, Zhi-Ying Bu, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 4, pp. 259-268
Open Access | Times Cited: 151
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease
Dan‐Qin Sun, Giovanni Targher, Christopher D. Byrne, et al.
HepatoBiliary Surgery and Nutrition (2023) Vol. 12, Iss. 3, pp. 386-403
Open Access | Times Cited: 59
Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications
Amedeo Lonardo, Alessandro Mantovani, Giovanni Targher, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13320-13320
Open Access | Times Cited: 40
Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis
Shreya C. Pal, Nahúm Méndez‐Sánchez
World Journal of Gastroenterology (2023) Vol. 29, Iss. 25, pp. 3999-4008
Open Access | Times Cited: 35
Steatotic liver disease, MASLD and risk of chronic kidney disease
Josh Bilson, Alessandro Mantovani, Christopher D. Byrne, et al.
Diabetes & Metabolism (2023) Vol. 50, Iss. 1, pp. 101506-101506
Open Access | Times Cited: 35
PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels
Dan‐Qin Sun, Kenneth I. Zheng, Gang Xu, et al.
Liver International (2019) Vol. 40, Iss. 1, pp. 107-119
Open Access | Times Cited: 76
Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
Alessandro Mantovani, Andrea Dalbeni, Giorgia Beatrice, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 968-968
Open Access | Times Cited: 29
PNPLA3I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings
Alessandro Mantovani, Alice Taliento, Chiara Zusi, et al.
Liver International (2020) Vol. 40, Iss. 5, pp. 1130-1141
Closed Access | Times Cited: 48
Nonalcoholic fatty liver disease and eGFR levels could be linked by the PNPLA3 I148M polymorphism in children with obesity
Pierluigi Marzuillo, Anna Di Sessa, Stefano Guarino, et al.
Pediatric Obesity (2019) Vol. 14, Iss. 10
Closed Access | Times Cited: 45
Adverse effect of PNPLA3 p.I148M genetic variant on kidney function in middle‐aged individuals with metabolic dysfunction
Alessandro Mantovani, Serena Pelusi, Sara Margarita, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 10, pp. 1093-1102
Open Access | Times Cited: 15
The Intersection of Genetic Factors, Aberrant Nutrient Metabolism and Oxidative Stress in the Progression of Cardiometabolic Disease
Andrew J Butcko, Ashley K. Putman, Emilio P. Mottillo
Antioxidants (2024) Vol. 13, Iss. 1, pp. 87-87
Open Access | Times Cited: 5
High uric acid, reduced glomerular filtration rate and non-alcoholic fatty liver in young people with obesity
Procolo Di Bonito, Giuliana Valerio, Maria Rosaria Licenziati, et al.
Journal of Endocrinological Investigation (2019) Vol. 43, Iss. 4, pp. 461-468
Closed Access | Times Cited: 41
PNPLA3 gene and kidney disease
Alessandro Mantovani, Chiara Zusi
Exploration of Medicine (2020) Vol. 1, Iss. 1, pp. 42-50
Open Access | Times Cited: 34
Regional insights into the relationship between metabolic associated steatotic liver disease and chronic kidney disease: a socioeconomic perspective on disease correlation
Jiang Bai, Lijuan Zhang, Mingyan Zhang, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese Children
Alessia Di Costanzo, Lucia Pacifico, Laura D’Erasmo, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4444-4444
Open Access | Times Cited: 35
Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease
Wen‐Yue Liu, Kenneth I. Zheng, Xiaoyan Pan, et al.
Journal of Gastroenterology and Hepatology (2019) Vol. 35, Iss. 6, pp. 1057-1064
Open Access | Times Cited: 30
New Perspectives on Genetic Prediction for Pediatric Metabolic Associated Fatty Liver Disease
Yu‐Cheng Lin, Chi-Chien Wu, Yen–Hsuan Ni
Frontiers in Pediatrics (2020) Vol. 8
Open Access | Times Cited: 29
Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges
Hsuan Yeh, Chun‐Cheng Chiang, Tzung‐Hai Yen
World Journal of Gastroenterology (2021) Vol. 27, Iss. 26, pp. 4104-4142
Open Access | Times Cited: 26
Interplay between metabolic dysfunction-associated fatty liver disease and renal function: An intriguing pediatric perspective
Michele Nardolillo, F. Rescigno, Mario Bartiromo, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 15, pp. 2081-2086
Open Access | Times Cited: 3
Genetic Factors Associated with Response to Vitamin E Treatment in NAFLD
Mehtap Civelek, Maren C. Podszun
Antioxidants (2022) Vol. 11, Iss. 7, pp. 1284-1284
Open Access | Times Cited: 15
Pediatric non-alcoholic fatty liver disease and kidney function: Effect of HSD17B13 variant
Anna Di Sessa, Giuseppina Rosaria Umano, Grazia Cirillo, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 36, pp. 5474-5483
Open Access | Times Cited: 22
Fatty kidney: A possible future for chronic kidney disease research
Mehmet Kanbay, Sidar Çöpür, Atalay Demiray, et al.
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 6
Closed Access | Times Cited: 14
Nonalcoholic Fatty Liver Disease and the Kidney: A Review
I. Umbro, Francesco Baratta, Francesco Angelico, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1370-1370
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top